Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gatifloxacin
Ketorolac LS
Pred Forte
Moxifloxacin
Nepafenac
EconoPred Plus
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients can be receiving monofocal IOLs only
* Likely to complete all study visits and able to provide informed consent
* Visual potential of 20/25 or better
Exclusion Criteria
* Active ocular diseases or uncontrolled systemic disease
* Active ocular allergies
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Innovative Medical
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William Trattler, MD
Role: PRINCIPAL_INVESTIGATOR
The Center For Excellence in Eye Care
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Center for Excellence in Eye Care
Miami, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5264-T
Identifier Type: -
Identifier Source: org_study_id